Results 151 to 160 of about 40,241 (253)

Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names [PDF]

, 2015

core   +1 more source

Knowledge and Attitude of Aseer Region Pharmacists Toward Biosimilar Medicines: A Descriptive Study. [PDF]

Healthcare (Basel)
Alqahtani S, Almanasef M.
europepmc   +1 more source

SP354PREDICTORS OF RENAL ANEMIA AND EPOETIN BIOSIMILAR THERAPY IN GERMAN HEMODIALYSIS PATIENTS [PDF]

, 2018
Helmut Reichel, Johannes Duttlinger, Danilo Fliser, Gerd Lonnemann   +3 more
openalex   +1 more source

Safety and Effectiveness of Multi-Switch Between Adalimumab Originator and Biosimilars: A Multicenter (SUSTAIN) Study. [PDF]

J Clin Med
Shehab M, Almajdi A, Abdullah I, Alrashed F.   +3 more
europepmc   +1 more source

AB043. Biosimilar medicines: a cross-sectional study on hospital pharmacists’ perceived confidence and barriers to promote prescribing among clinicians in Malaysia

, 2021
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman   +2 more
openalex   +1 more source

An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany. [PDF]

Front Public Health
Raitner I, Müller B, Vijayan A, Zimmermann L, Bramlage P, Ness NH, Müller M.   +6 more
europepmc   +1 more source

Sandoz Inc. v. Amgen Inc.: Removing Barriers to Market Access for Biosimilar Manufacturers [PDF]

, 2019
Koya, Moyosore O.
core   +1 more source

Pharmacokinetics, efficacy and safety of the rituximab biosimilar CT-P10 [PDF]

, 2017
Bertrand Coiffier
openalex   +1 more source

Exploring Stakeholder Perceptions and Experience of Biosimilar Insulin Switching: A Scoping Review. [PDF]

Endocrinol Diabetes Metab
Hindley B, Wright S, Ooi C, Da Costa R, Cope L.   +4 more
europepmc   +1 more source

A Look Beyond the Biosimilarity of the Molecules. [PDF]

, 2015
Michetti, P.
core   +1 more source